Skip to main content

Curis Inc

CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001108205

No open-market purchases or sales by Curis Inc insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $7.96M in total; Maverick Capital is the only superinvestor holding it.

Q1 2024 vs. Q4 2023

How the institutions holding Curis Inc changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of CRIS: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders3836−2
Shares2.05M2.09M+39.0K (+1.9%)
Value$26.1M$22.7M−$3.43M (−13.1%)

New holders (5)

Institutions that held Curis Inc at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to CRIS in Q1 2024
InstitutionSharesValue% of portfolio
Franklin Street Advisors Inc20,128$219.0K0.02%
Point72 Asset Management, L.P.12,100$131.5K0.00%
CIBC Private Wealth Group, LLC12$1520.00%
TruNorth Capital Management, LLC1$110.00%
WR Wealth Planners, LLC1$110.00%

Sold out (7)

Institutions that held Curis Inc at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of CRIS in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Artal Group S.A.105,000$1.34M
Natixis500$6.38K
LM Advisors LLC200$2.55K
Harbour Investments, Inc.58$740
FMR LLC9$115
Vima LLC3$38
Ronald Blue Trust, Inc.17$0